CD274 and small cell lung carcinoma: For instance, a combination of programmed cell death‐ligand 1 (PD‐L1) inhibitor with platinum‐etoposide chemotherapy as first‐line treatment options for ED‐SCLC prolongs the median OS by 2–3 months.9, 10